Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.
Advertisement
International news in seven languages
Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.

Moderna's stock fell even though the full data, released later Thursday, appeared positive based on Wall Street expectations ahead of the release.